These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 22126380)
21. Overexpression of Her2/neu, estrogen and progesterone receptors in invasive micropapillary carcinoma of the breast. Kuroda H; Sakamoto G; Ohnisi K; Itoyama S Breast Cancer; 2004; 11(3):301-6. PubMed ID: 15550850 [TBL] [Abstract][Full Text] [Related]
22. Invasive micropapillary carcinoma of the breast metastatic to the urinary bladder and endometrium: diagnostic pitfalls and review of the literature of tumors with micropapillary features. Ramalingam P; Middleton LP; Tamboli P; Troncoso P; Silva EG; Ayala AG Ann Diagn Pathol; 2003 Apr; 7(2):112-9. PubMed ID: 12715337 [TBL] [Abstract][Full Text] [Related]
23. Expression of cell adhesion molecules, CD44s and E-cadherin, and microvessel density in invasive micropapillary carcinoma of the breast. Gong Y; Sun X; Huo L; Wiley EL; Rao MS Histopathology; 2005 Jan; 46(1):24-30. PubMed ID: 15656882 [TBL] [Abstract][Full Text] [Related]
24. Fine-needle aspiration biopsy of invasive micropapillary carcinoma of the breast: a report of five cases. Bayramoglu H; Zekioglu O; Erhan Y; Ciriş M; Ozdemir N Diagn Cytopathol; 2002 Oct; 27(4):214-7. PubMed ID: 12357498 [TBL] [Abstract][Full Text] [Related]
25. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma. Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793 [TBL] [Abstract][Full Text] [Related]
26. Breast carcinoma with micropapillary features: clinicopathologic study and long-term follow-up of 100 cases. Chen L; Fan Y; Lang RG; Guo XJ; Sun YL; Cui LF; Liu FF; Wei J; Zhang XM; Fu L Int J Surg Pathol; 2008 Apr; 16(2):155-63. PubMed ID: 18417672 [TBL] [Abstract][Full Text] [Related]
27. [Expression of Ezrin and E-cadherin in invasive ductal breast cancer and their correlations to lymphatic metastasis]. Li Q; Wu MF; Song AP; Wei JC; Xu G; Lu YP; Ma D Ai Zheng; 2006 Mar; 25(3):363-6. PubMed ID: 16536996 [TBL] [Abstract][Full Text] [Related]
28. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study. Ottesen GL APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968 [TBL] [Abstract][Full Text] [Related]
29. Invasive micropapillary carcinoma of the breast. A new special type of invasive mammary carcinoma. Luna-Moré S; Gonzalez B; Acedo C; Rodrigo I; Luna C Pathol Res Pract; 1994 Aug; 190(7):668-74. PubMed ID: 7808965 [TBL] [Abstract][Full Text] [Related]
30. Gastric carcinoma with invasive micropapillary pattern and its association with lymph node metastasis. Ushiku T; Matsusaka K; Iwasaki Y; Tateishi Y; Funata N; Seto Y; Fukayama M Histopathology; 2011 Dec; 59(6):1081-9. PubMed ID: 22175888 [TBL] [Abstract][Full Text] [Related]
31. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast. Hussein MR; Abd-Elwahed SR; Abdulwahed AR Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077 [TBL] [Abstract][Full Text] [Related]
32. Intraductal spread of invasive breast carcinoma has a positive correlation with c-erb B-2 overexpression and vascular invasion. Jing X; Kakudo K; Murakami M; Nakamura Y; Nakamura M; Yokoi T; Yang Q; Oura S; Sakurai T Cancer; 1999 Aug; 86(3):439-48. PubMed ID: 10430252 [TBL] [Abstract][Full Text] [Related]
33. Activated Akt signaling pathway in invasive ductal carcinoma of the breast: correlation with HER2 overexpression. Park SS; Kim SW Oncol Rep; 2007 Jul; 18(1):139-43. PubMed ID: 17549359 [TBL] [Abstract][Full Text] [Related]
34. Atypical tumor-stromal fibroblasts in invasive ductal carcinoma of the breast. Hasebe T; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Kinoshita T; Tsuda H Am J Surg Pathol; 2011 Mar; 35(3):325-36. PubMed ID: 21317705 [TBL] [Abstract][Full Text] [Related]
35. Clinicopathologic analysis of invasive micropapillary differentiation in breast carcinoma. Nassar H; Wallis T; Andea A; Dey J; Adsay V; Visscher D Mod Pathol; 2001 Sep; 14(9):836-41. PubMed ID: 11557778 [TBL] [Abstract][Full Text] [Related]
36. Elevated cyclooxygenase-2 expression is associated with histological grade in invasive ductal breast carcinoma. Takeshita E; Osanai T; Higuchi T; Soumaoro LT; Sugihara K J Med Dent Sci; 2005 Dec; 52(4):189-93. PubMed ID: 16669452 [TBL] [Abstract][Full Text] [Related]
37. Clinicopathological study of the expression of syndecan-1 in invasive breast carcinomas. correlation with extracellular matrix components. Tsanou E; Ioachim E; Briasoulis E; Charchanti A; Damala K; Karavasilis V; Pavlidis N; Agnantis NJ J Exp Clin Cancer Res; 2004 Dec; 23(4):641-50. PubMed ID: 15743035 [TBL] [Abstract][Full Text] [Related]
38. Mucinous micropapillary carcinoma of the breast: an aggressive counterpart to conventional pure mucinous tumors. Barbashina V; Corben AD; Akram M; Vallejo C; Tan LK Hum Pathol; 2013 Aug; 44(8):1577-85. PubMed ID: 23517923 [TBL] [Abstract][Full Text] [Related]
39. Pleomorphic ductal carcinoma of the breast with predominant micropapillary features. Lenicek T; Szerda F; Demirović A; Mijić A; Kruslin B; Tomas D Pathol Int; 2007 Oct; 57(10):694-7. PubMed ID: 17803659 [TBL] [Abstract][Full Text] [Related]
40. Clinicopathological parameters and biological markers predicting non-sentinel node metastasis in sentinel node-positive breast cancer patients. Kwon Y; Ro J; Kang HS; Kim SK; Hong EK; Khang SK; Gong G; Ro JY Oncol Rep; 2011 Apr; 25(4):1063-71. PubMed ID: 21258771 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]